Preprint Communication Version 1 This version is not peer-reviewed

An Anti-Mouse CXCR5 Monoclonal Antibody (Cx5Mab-3) Shows High Affinity for Flow Cytometry

Version 1 : Received: 7 October 2024 / Approved: 7 October 2024 / Online: 8 October 2024 (08:54:06 CEST)

How to cite: Ishikawa, K.; Suzuki, H.; Tanaka, T.; Kaneko, M. K.; Kato, Y. An Anti-Mouse CXCR5 Monoclonal Antibody (Cx5Mab-3) Shows High Affinity for Flow Cytometry. Preprints 2024, 2024100497. https://doi.org/10.20944/preprints202410.0497.v1 Ishikawa, K.; Suzuki, H.; Tanaka, T.; Kaneko, M. K.; Kato, Y. An Anti-Mouse CXCR5 Monoclonal Antibody (Cx5Mab-3) Shows High Affinity for Flow Cytometry. Preprints 2024, 2024100497. https://doi.org/10.20944/preprints202410.0497.v1

Abstract

The CXC chemokine receptor 5 (CXCR5) is a member of the G protein-coupled receptor family that is highly expressed in B cells and a subset of T cells such as T follicular helper cells. Various types of cancers, including non-small cell lung cancer, breast cancer, and prostate cancer also express CXCR5; therefore, antibodies that specifically bind to CXCR5 could be useful for clarification of the mechanisms of cancer progression. In this study, we aimed to develop high-affinity monoclonal antibodies (mAbs) for flow cytometry against mouse CXCR5 (mCXCR5). The established anti-mCXCR5 mAb, Cx5Mab-3 (rat IgG2b, kappa), reacted with mCXCR5-overexpressed Chinese hamster ovary (CHO)-K1 (CHO/mCXCR5) by flow cytometry. Kinetic analyses using flow cytometry indicated that the dissociation constants (KD) of Cx5Mab-3 for CHO/mCXCR5 is 7.2 × 10−10 M, indicating that Cx5Mab-3 is useful for detecting mCXCR5 by flow cytometry with high affinity.

Keywords

mouse CXCR5; monoclonal antibody; peptide immunization; flow cytometry

Subject

Medicine and Pharmacology, Pathology and Pathobiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.